Postoperative pancreatic fistula formation according to ISGPF criteria after D2 gastrectomy in Western patients.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 24105422)

Published in Gastric Cancer on October 09, 2013

Authors

Chih-Han Kung1, Mats Lindblad, Magnus Nilsson, Ioannis Rouvelas, Koshi Kumagai, Lars Lundell, Jon A Tsai

Author Affiliations

1: Department of Clinical Science, Intervention and Technology, Division of Surgery, Karolinska Institutet and Karolinska University Hospital, Huddinge, GastroCentrum kirurgi K53, 141 81, Stockholm, Sweden.

Associated clinical trials:

Incidence of Pancreatic Fistula After Radical Gastrectomy | NCT03391687

Articles cited by this

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13

Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery (2005) 16.42

Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet (1995) 7.64

Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43

Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet (1996) 7.24

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer (1999) 6.76

Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol (2006) 4.38

Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. J Clin Oncol (2004) 4.31

Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47

Pancreatic fistula rate after pancreatic resection. The importance of definitions. Dig Surg (2003) 2.26

Amylase concentration of drainage fluid after total gastrectomy. Br J Surg (1997) 1.71

Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: results of a randomized controlled trial. World J Surg (2011) 1.70

Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg (2010) 1.69

Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg (1995) 1.62

Pancreatic resection additional to gastrectomy for gastric cancer. Effect on postoperative morbidity. Acta Chir Scand (1986) 1.27

Feasibility of laparoscopic gastrectomy with radical lymph node dissection for gastric cancer: from a viewpoint of pancreas-related complications. Surgery (2010) 1.19

Postoperative pancreatic fistula and the risk factors of laparoscopy-assisted distal gastrectomy for early gastric cancer. Ann Surg Oncol (2011) 1.09

Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer. Ann Surg Oncol (2012) 1.03

Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg (2004) 1.03

Total gastrectomy with simultaneous pancreaticosplenectomy or splenectomy in patients with advanced gastric carcinoma. Br J Cancer (1999) 1.01

Postoperative complications following gastrectomy for gastric cancer during the last decade. Hepatogastroenterology (2004) 1.01

Management of complications after gastrectomy with extended lymphadenectomy. Surg Oncol (2000) 1.01

Influence of overweight on patients with gastric cancer after undergoing curative gastrectomy: an analysis of 689 consecutive cases managed by a single center. Arch Surg (2009) 1.00

Evaluation of postoperative pancreatic fistula after total gastrectomy with D2 lymphadenectomy by ISGPF classification. J Gastrointest Surg (2011) 0.98

Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy. Br J Surg (2012) 0.91

Utility of drain fluid amylase measurement on the first postoperative day after pancreaticoduodenectomy. World J Surg (2012) 0.90

Drain versus no-drain after gastrectomy for patients with advanced gastric cancer: systematic review and meta-analysis. Dig Surg (2011) 0.88

Indications for pancreaticosplenectomy in advanced gastric cancer. Hepatogastroenterology (2001) 0.83

Predictive factors for pancreatic fistula after pancreaticosplenectomy for advanced gastric cancer in the upper third of the stomach. J Gastrointest Surg (2006) 0.81

Impact of pancreatic gland volume on fistula formation after pancreatic tail resection. JOP (2010) 0.80

Articles by these authors

Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA (2011) 4.74

The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology (2006) 3.80

A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology (2004) 3.50

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68

The effect of prophylactic transpapillary pancreatic stent insertion on clinically significant leak rate following distal pancreatectomy: results of a prospective controlled clinical trial. Ann Surg (2012) 2.21

Iatrogenic bile duct injury: a population-based study of 152 776 cholecystectomies in the Swedish Inpatient Registry. Arch Surg (2006) 2.02

Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer (2006) 1.59

Effect of intended intraoperative cholangiography and early detection of bile duct injury on survival after cholecystectomy: population based cohort study. BMJ (2012) 1.48

Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol (2008) 1.46

The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol (2002) 1.45

Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg (2006) 1.44

Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol (2009) 1.42

Impact of hospital volume on long-term survival after esophageal cancer surgery. Arch Surg (2007) 1.38

Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol (2005) 1.34

Impact of choice of therapeutic strategy for acute cholecystitis on patient's health-related quality of life. Results of a randomized, controlled clinical trial. Dig Surg (2004) 1.30

Intrathoracic anastomotic leakage and mortality after esophageal cancer resection: a population-based study. Ann Surg Oncol (2011) 1.25

Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg (2003) 1.20

Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target. Angew Chem Int Ed Engl (2010) 1.19

Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med (2010) 1.18

Three-step esophagojejunal anastomosis with atraumatic anvil insertion technique after laparoscopic total gastrectomy. J Gastrointest Surg (2011) 1.16

Advances in the treatment of patients with gastric adenocarcinoma. Acta Oncol (2007) 1.10

Sex differences in the incidence of gastrointestinal adenocarcinoma in Sweden 1970-2006. Eur J Cancer (2010) 1.09

Postoperative pancreatic fistula and the risk factors of laparoscopy-assisted distal gastrectomy for early gastric cancer. Ann Surg Oncol (2011) 1.09

Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol (2013) 1.07

Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350. Bioorg Med Chem Lett (2008) 1.06

Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor. J Med Chem (2014) 1.05

Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection. World J Surg (2005) 1.05

Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma. Gastric Cancer (2008) 1.04

Nationwide, population-based data from 11,074 ERCP procedures from the Swedish Registry for Gallstone Surgery and ERCP. Gastrointest Endosc (2010) 1.03

Long-term outcome and survival with laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer. Surg Endosc (2010) 1.02

Phase II study of chemoradiotherapy with S-1 and low-dose cisplatin for inoperable advanced gastric cancer. Int J Radiat Oncol Biol Phys (2007) 1.01

Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences. Acta Oncol (2007) 1.01

The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trøndelag health survey. Chest (2006) 1.00

Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial. Am J Gastroenterol (2009) 1.00

Postoperative outcomes and complications after laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer. Ann Surg (2011) 0.99

Quantitative risk assessment of thermophilic Campylobacter spp. and cross-contamination during handling of raw broiler chickens evaluating strategies at the producer level to reduce human campylobacteriosis in Sweden. Int J Food Microbiol (2007) 0.99

The effect of mosapride on oesophageal motor function and acid reflux in patients with gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol (2003) 0.99

Endoscopic sphincterotomy and risk of malignancy in the bile ducts, liver, and pancreas. Clin Gastroenterol Hepatol (2008) 0.98

Tamoxifen exposure in relation to gastric adenocarcinoma development. Eur J Cancer (2008) 0.96

Endoscopic assessment and grading of Barrett's esophagus using magnification endoscopy and narrow-band imaging: accuracy and interobserver agreement of different classification systems (with videos). Gastrointest Endosc (2011) 0.95

Stone clearance and risk factors for failure in laparoscopic transcystic exploration of the common bile duct. Surg Endosc (2008) 0.95

Reliability of acute pancreatitis diagnosis coding in a National Patient Register: a validation study in Sweden. Pancreatology (2011) 0.95

Transhepatic placement of an enteral stent to treat jaundice in a tumor recurrence obstructed afferent loop after a whipple procedure. Dig Surg (2003) 0.94

Standardization of surgical technique in antireflux surgery: the LOTUS Trial experience. World J Surg (2008) 0.94

Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study. JAMA Intern Med (2013) 0.93

Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease. Acta Paediatr (2006) 0.93

Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study). Helicobacter (2007) 0.93

Autophagic-lysosomal pathway is the main proteolytic system modified in the skeletal muscle of esophageal cancer patients. Am J Clin Nutr (2013) 0.92

Deoxynivalenol and other selected Fusarium toxins in Swedish oats--occurrence and correlation to specific Fusarium species. Int J Food Microbiol (2013) 0.91

Acid challenge to the human esophageal mucosa: effects on epithelial architecture in health and disease. Dig Dis Sci (2005) 0.90

Obesity alters cytokine gene expression and promotes liver injury in rats with acute pancreatitis. Obesity (Silver Spring) (2008) 0.90

Frequent occurrence of extended-spectrum beta-lactamase- and transferable ampc beta-lactamase-producing Escherichia coli on domestic chicken meat in Sweden. Appl Environ Microbiol (2013) 0.89

Efficacy of an anterior as compared with a posterior laparoscopic partial fundoplication: results of a randomized, controlled clinical trial. Ann Surg (2003) 0.88

Long-term effects of iatrogenic bile duct injury during cholecystectomy. Clin Gastroenterol Hepatol (2009) 0.88

Total or posterior partial fundoplication in the treatment of GERD: results of a randomized trial after 2 decades of follow-up. Ann Surg (2011) 0.88

Long-term efficacy of total (Nissen-Rossetti) and posterior partial (Toupet) fundoplication: results of a randomized clinical trial. J Gastrointest Surg (2002) 0.87

Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update. Surgery (2012) 0.87

Endoscopic assessment and grading of Barrett's esophagus using magnification endoscopy and narrow band imaging: impact of structured learning and experience on the accuracy of the Amsterdam classification system. Scand J Gastroenterol (2012) 0.87

Supportive nutrition on recovery of metabolism, nutritional state, health-related quality of life, and exercise capacity after major surgery: a randomized study. Clin Gastroenterol Hepatol (2005) 0.86

Actions by angiotensin II on esophageal contractility in humans. Gastroenterology (2006) 0.86

International registries of families at high risk of pancreatic cancer. Pancreatology (2008) 0.86

Inactivation of Escherichia coli, Listeria monocytogenes and Yersinia enterocolitica in fermented sausages during maturation/storage. Int J Food Microbiol (2008) 0.85

Rendezvous cannulation technique reduces post-ERCP pancreatitis: a prospective nationwide study of 12,718 ERCP procedures. Am J Gastroenterol (2013) 0.85

Risk factors and chemoprevention in Barrett's esophagus--an update. Scand J Gastroenterol (2012) 0.85

Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors. Bioorg Med Chem Lett (2008) 0.83

Physical function and quality of life after thoracoabdominal oesophageal resection. Results of a follow-up study. Dig Surg (2005) 0.83

Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events. Clin Gastroenterol Hepatol (2012) 0.83

Treatment of achalasia with laparoscopic myotomy or pneumatic dilatation: long-term results of a prospective, randomized study. World J Surg (2015) 0.83

Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications. Eur J Gastroenterol Hepatol (2013) 0.83

Time to growth and inactivation of three STEC outbreak strains under conditions relevant for fermented sausages. Int J Food Microbiol (2010) 0.82

Survival after neoadjuvant therapy compared with surgery alone for resectable esophageal cancer in a population-based study. World J Surg (2006) 0.82

Functional long-term outcome of a free jejunal transplant reconstruction following chemoradiotherapy and radical resection for hypopharyngeal and proximal oesophageal carcinoma. Dig Surg (2004) 0.81

Further studies on serrated neoplasias of the cardia: a review and case report. Anticancer Res (2008) 0.81

Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study. Pancreatology (2010) 0.81

Canadian academy of geriatric psychiatry survey of brief cognitive screening instruments. Can Geriatr J (2013) 0.81

Discovery of novel, potent and bioavailable proline-urea based macrocyclic HCV NS3/4A protease inhibitors. Bioorg Med Chem Lett (2008) 0.81

2'-Deoxy-2'-spirocyclopropylcytidine revisited: a new and selective inhibitor of the hepatitis C virus NS5B polymerase. J Med Chem (2010) 0.81

One-lung ventilation during thoracoabdominal esophagectomy elicits complement activation. J Surg Res (2008) 0.81

Surgeon volume is a poor proxy for skill in esophageal cancer surgery. Ann Surg (2009) 0.81

Laparoscopy-assisted subtotal gastrectomy with very small remnant stomach: a novel surgical procedure for selected early gastric cancer in the upper stomach. Gastric Cancer (2011) 0.80

Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study. Clin Gastroenterol Hepatol (2007) 0.80

Non-malignant respiratory tract fistula from the oesophagus. A lethal condition for which novel therapeutic options are emerging. Interact Cardiovasc Thorac Surg (2012) 0.80

Impact of pancreatic gland volume on fistula formation after pancreatic tail resection. JOP (2010) 0.80

Increased central memory T cells in patients with chronic pancreatitis. Pancreatology (2005) 0.79

Mechanical consequences of short gastric vessel division at the time of laparoscopic total fundoplication. J Gastrointest Surg (2004) 0.79

Feasibility of imaging esophageal cancer with labeled somatostatin analogue. Int J Mol Imaging (2011) 0.79

The clinicopathological spectrum and management of intraductal papillary mucinous neoplasm of the bile duct (IPMN-B). Scand J Gastroenterol (2013) 0.79

Losartan to prevent hyperenzymemia after endoscopic retrograde cholangiopan-creatography: A randomized clinical trial. World J Gastrointest Endosc (2012) 0.79

Antiviral activity and mode of action of TMC647078, a novel nucleoside inhibitor of the hepatitis C virus NS5B polymerase. Antimicrob Agents Chemother (2011) 0.79

Treatment of postoperative esophagorespiratory fistulas with dual self-expanding metal stents. World J Surg (2009) 0.79

Significance of the inflammation-based Glasgow prognostic score for short- and long-term outcomes after curative resection of gastric cancer. J Gastrointest Surg (2012) 0.78

Asymmetric cerebral blood flow in patients with mild cognitive impairment: possible relationship to further cognitive deterioration. Dement Geriatr Cogn Dis Extra (2011) 0.78

Endoscopic retrograde cholangiopancreatography with rendezvous cannulation reduces pancreatic injury. World J Gastroenterol (2013) 0.78

Continuous assessment of intrahepatic metabolism by microdialysis during and after portal triad clamping. J Surg Res (2010) 0.77

Correlation between preoperative imaging and intraoperative risk assessment in the prediction of postoperative pancreatic fistula following pancreatoduodenectomy. World J Surg (2014) 0.77